Comprehensive analysis reveals SH3GLB1 influences cancer treatment efficacy as a prognostic biomarker, suggesting its therapeutic potential.
SH3GLB1 exhibits significant diversity and complexity in its tumor-suppressive functions, highlighting its potential as a promising biomarker and therapeutic target for improving the efficacy of cancer treatments.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: